ArticleBMJ open2024

Measuring and predicting the effect of remyelinating therapy in multiple sclerosis: a randomised controlled trial protocol (RESTORE).

Sam Hof et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.